INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

The Greater Pennsylvania chapter of the Alzheimer’s Association says it’s been a productive and exciting year when it comes ...

Although we don't know a lot about the causes of Alzheimer's disease, the following conditions may raise your risk.

As the year comes to a close, experts from the Alzheimer's Association reflect on some of the hopeful advances in diagnosis, ...

Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...

The daily medication, called hydromethylthionine mesylate (HMTM), was developed by British firm TauRX in Aberdeen ...

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS. Regulators are due to ...

Alzheimer's is the most common cause of dementia and researchers say their findings could lead to treatments that could slow ...

Even as new drugs come to market, further study appears to point to infections as a possible cause for the debilitating ...

Taken as a tablet, it would not require the complex infusions needed for other recent breakthrough Alzheimer’s treatments. Early trial data suggests it can slow progression of the disease with ...

Researchers from Arizona State University and Banner Alzheimer’s Institute have discovered a surprising link between a common ...